India alone witnesses two million new cases every year with at least a third of them requiring advanced therapy to survive, says Dr. Kunal Sarkar of Medica Superspecialty Hospital.
KOLKATA, Mar 25 (The CONNECT) – In a first artificial heart implant in Eastern India, Medica Superspecialty Hospital has conducted a critical operation for around 6 hours to save a 54-year-old man.
Described as an ingenuous marvel in the treatment of heart implants the first LVAD (Left Ventricular Assist Device) was done by the team of experienced doctors from departments of Cardiac Surgery, CTVS and Cardiology.
Sudheer Kumar Singh (name changed) had suffered a severe heart attack 12 weeks ago. The patient suffered an acute damage to his cardiac function.
Dr. Kunal Sarkar, Senior Vice Chairman, Director and Head of Cardiac Surgery at Medica Superspecialty Hospital who led the team of surgeons said, “The patient had visited us in a critically ill state with a failing heart and rapidly deteriorating health. We had no recourse but advise to undergo a heart transplantation or artificial heart implant. Since this was the first of its kind in this part of the country, we were extra cautious and currently after a successful surgery, he is under constant monitoring of his implant.”
“The Artificial Heart Device (Heartmate 2) is a cutting edge, titanium Impeller pump with ruby bearings, which pumps blood at 9000- 12000 revolutions per minute. It works on electric current and wearable batteries that needs to be recharged every 12 hours. They are mobile and once patients recover; they can be physically active,” Dr Sarkar explained. “We aim to be one of the main South Asian Centers for Advanced Cardiopulmonary Support,” he said.
The team put in their combined efforts under the leadership of Dr. Sarkar, comprised of Prof. Dr. Rabin Chakraborty, Senior Vice Chairman Medica Superspecialty Hospital, Dr. Dilip Kumar, Senior Consultant & Director Cath Lab Services, Department of Cardiology, Dr. Saptarshi Roy, Senior Consultant & Cardiac Surgeon, and experienced CTVS team, Dr. Arpan Chakraborty and Dr. Dipanjan Chatterjee.
Heart failure is a major global health concern. Every year, 20 million people world-wide suffer from heart failure, and India alone witnesses two million new cases every year with at least a third of them requiring advanced therapy to survive. The mortality rate in heart failure patients is as high as 30-40%, within a year of diagnosis. In India, the treatment for heart failure is restricted to medical therapy, revascularization therapy - restoration/augmentation of blood supply to the heart-, valvular surgeries and cardiac resynchronization (heart pacing) therapy.
Dr. Alok Roy, Chair FICCI Health Services Committee and Chairman, Medica Group of Hospitals, stated, advances in science and medicine have made heart transplants safer and a real option in managing cases of end stage heart failure.
Cardiac care at Medica Superspecialty Hospital is well established and ranked amongst the finest in the country. Medica Group of Hospitals, one of the major and fast-growing chains of hospitals in Eastern India today, has built and managed numerous healthcare facilities across the Eastern region over the past few years. The healthcare chain launched its operations with Medica North Bengal Clinic (MNBC) in Siliguri in 2008 and soon followed up with its flagship Hospital – Medica Superspecialty Hospital (MSH) – in Kolkata in 2010. The group has footprints in West Bengal, Jharkhand, Odisha, Bihar, and Assam.